Logopedie bij de ziekte van Parkinson - Logopedie.nl

156
Logopedie bij de ziekte van Parkinson
(119) Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in parkinson’s
disease is closely associated with psychiatric symptoms, falls, and disability.
Parkinsonism Relat Disord 2006 Jan;12(1):35-41.
(120) Martinez-Martin P, Forjaz MJ, Frades-Payo B, Rusinol AB, Fernandez-Garcia JM,
Ito-Leon J, et al. Caregiver burden in Parkinson’s disease. Mov Disord 2007 May
15;22(7):924-31.
(121) Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson’s disease. Ann Neurol
1992;32 Suppl:S125-S127.
(122) Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol
1999 Jan;56(1):33-9.
(123) Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet 2004 May 29;363(9423):
1783-93.
(124) Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic
Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg
Psychiatry 1992 Mar;55(3):181-4.
(125) Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson’s disease. Lancet Neurol
2006 Jan;5(1):75-86.
(126) Ziekenfondsraad. Farmacotherapeutisch Kompas 2007. Amstelveen: Ziekenfondsraad;
2007.
(127) Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, et al. Review
of the therapeutic management of Parkinson’s disease. Report of a joint task force
of the European Federation of Neurological Societies and the Movement Disorder
Society-European Section. Part I: early (uncomplicated) Parkinson’s disease. Eur J
Neurol 2006 Nov;13(11):1170-85.
(128) Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive
behaviors in Parkinson’s disease. Curr Opin Neurol 2007 Aug;20(4):484-92.
(129) Meningaud JP, Pitak-Arnnop P, Chikhani L, Bertrand JC. Drooling of saliva: a review of
the etiology and management options. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2006 Jan;101(1):48-57.
(130) Postma AG, Heesters M, van LT. Radiotherapy to the salivary glands as treatment of
sialorrhea in patients with parkinsonism. Mov Disord 2007 Dec;22(16):2430-5.
(131) Martinez-Martin P, Deuschl G. Effect of medical and surgical interventions on healthrelated
quality of life in Parkinson’s disease. Mov Disord 2007 Apr 30;22(6):757-65.
(132) Moro E, Lang AE. Criteria for deep-brain stimulation in Parkinson’s disease: review
and analysis. Expert Rev Neurother 2006 Nov;6(11):1695-705.
(133) Pinto S, Thobois S, Costes N, Le BD, Benabid AL, Broussolle E, et al. Subthalamic
nucleus stimulation and dysarthria in Parkinson’s disease: a PET study. Brain 2004
Mar;127(Pt 3):602-15.
(134) Tornqvist AL, Schalen L, Rehncrona S. Effects of different electrical parameter settings
on the intelligibility of speech in patients with Parkinson’s disease treated with
subthalamic deep brain stimulation. Mov Disord 2005 Apr;20(4):416-23.